EIPM Seminar Series Event: Dr. Anna Woloszynska

Englander Institute for Precision Medicine Presents: "Identifying Biomarkers and Potential Treatment Targets in Prostate Cancer Health Disparities" Presented by: Anna Woloszynska, Ph.D. Associate Professor of Oncology Pharmacology and Therapeutics Roswell Park Anna Woloszynska, PhD, is an Associate Professor of Oncology in the Department of Pharmacology and Therapeutics at Roswell Park Comprehensive Cancer Center and a graduate faculty member at the State University of New York at Buffalo. She is actively involved in the NCI Cancer Center Support Grant (CCSG) Developmental Therapeutics (DT) program. Dr. Woloszynska has developed a functional genomics research program that focuses on the genetics and epigenetics of bladder and prostate cancer, aiming to uncover new tumor vulnerabilities and develop effective treatments. Her bladder cancer research centers on the cohesin complex member STAG2 and chromatin modifiers. In prostate cancer, she addresses racial disparities, with a particular focus on early-onset cases in African American men.